This article asks whether Novo Nordisk is merely buying tomorrow's medicines from Orbis or quietly helping to train an AI discovery platform that could ultimately own the intelligence behind them.
The second-largest pharmaceutical company in Denmark is Lundbeck, specialising in treatments for neurological and psychiatric disorders.
Denmark’s pharmaceutical industry features innovative mid-sized firms, strong research links, and global exports, particularly in biotech and specialized therapeutics.